DK317283D0 - Fremgangsmade til fremstilling af thiadiazolderivater - Google Patents

Fremgangsmade til fremstilling af thiadiazolderivater

Info

Publication number
DK317283D0
DK317283D0 DK3172/83A DK317283A DK317283D0 DK 317283 D0 DK317283 D0 DK 317283D0 DK 3172/83 A DK3172/83 A DK 3172/83A DK 317283 A DK317283 A DK 317283A DK 317283 D0 DK317283 D0 DK 317283D0
Authority
DK
Denmark
Prior art keywords
thiadiazold
derivatives
procedure
preparation
thiadiazold derivatives
Prior art date
Application number
DK3172/83A
Other languages
English (en)
Other versions
DK317283A (da
Inventor
Barry John Price
Roger Hayes
David Edmund Bays
John Wilson Macfarla Mackinnon
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK317283D0 publication Critical patent/DK317283D0/da
Publication of DK317283A publication Critical patent/DK317283A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DK317283A 1982-07-08 1983-07-08 Fremgangsmaade til fremstilling af thiadiazolderivater DK317283A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8219746 1982-07-08

Publications (2)

Publication Number Publication Date
DK317283D0 true DK317283D0 (da) 1983-07-08
DK317283A DK317283A (da) 1984-01-09

Family

ID=10531541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK317283A DK317283A (da) 1982-07-08 1983-07-08 Fremgangsmaade til fremstilling af thiadiazolderivater

Country Status (11)

Country Link
JP (1) JPS5927880A (da)
AU (1) AU1666583A (da)
BE (1) BE897247A (da)
DE (1) DE3324771A1 (da)
DK (1) DK317283A (da)
FR (1) FR2532937A1 (da)
GB (1) GB2124622A (da)
IT (1) IT8348653A0 (da)
NL (1) NL8302450A (da)
SE (1) SE8303913L (da)
ZA (1) ZA835009B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors
DE3326545A1 (de) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3408327A1 (de) * 1984-03-07 1985-09-12 Ludwig Heumann & Co GmbH, 8500 Nürnberg Diaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PE20040570A1 (es) 2002-10-09 2004-08-30 Pharmacopeia Drug Discovery Tiadiazoldioxidos y tiadiazoloxidos como ligandos del receptor de cxc- y cc-quimiocina
US7338968B2 (en) 2003-12-19 2008-03-04 Schering Corporation Thiadiazoles AS CXC- and CC- chemokine receptor ligands
TW200530231A (en) 2003-12-22 2005-09-16 Schering Corp Isothiazole dioxides as CXC-and CC-chemokine receptor ligands
WO2007005403A1 (en) 2005-06-29 2007-01-11 Schering Corporation 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
CN101253165A (zh) 2005-06-29 2008-08-27 先灵公司 作为cxc-化学活素受体配体的二取代的二唑
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors

Also Published As

Publication number Publication date
SE8303913L (sv) 1984-01-09
GB2124622A (en) 1984-02-22
BE897247A (fr) 1984-01-09
AU1666583A (en) 1984-01-12
FR2532937A1 (fr) 1984-03-16
DK317283A (da) 1984-01-09
ZA835009B (en) 1985-02-27
SE8303913D0 (sv) 1983-07-08
JPS5927880A (ja) 1984-02-14
GB8318525D0 (en) 1983-08-10
DE3324771A1 (de) 1984-01-12
NL8302450A (nl) 1984-02-01
IT8348653A0 (it) 1983-07-08

Similar Documents

Publication Publication Date Title
DK301383A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK1183D0 (da) Fremgangsmade til fremstilling af tiazolidinderivater
DK95483A (da) Fremgangsmaade til fremstilling af tetrahydropyranderivater
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK372283A (da) Fremgangsmaade til fremstilling af desoxyuridinderivater
DK63683D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK323083D0 (da) Fremgangsmade til fremstilling af 19-thio-androstanderivater
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK435483D0 (da) Fremgangsmade til fremstilling af fenylcyklobutylderivater
DK427083D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK261883A (da) Fremgangsmaade til fremstilling af prostaglandin-d-derivater
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK317283A (da) Fremgangsmaade til fremstilling af thiadiazolderivater
DK426683D0 (da) Fremgangsmade til fremstilling af oxacephalosporinderivater
DK340483D0 (da) Fremgangsmade til fremstilling af fluoralkylerede carbapenemderivater
DK482983A (da) Fremgangsmaade til fremstilling af phenylderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK542383D0 (da) Fremgangsmade til fremstilling af acridanonderivater
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK62283D0 (da) Fremgangsmade til fremstilling af peptidergotalkaloider
DK164283D0 (da) Fremgangsmade til fremstilling af benzimidazolderivater
DK10883D0 (da) Fremgangsmade til fremstilling af substituerede chloracetanilider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment